Table 2 Distribution of pathogens associated with intensive care unit-associated infections and their antimicrobial resistance patterns, Ain Shams University Hospitals, Egypt, March 2018–February 2019
Pathogen type and pattern of resistance | n | Resistance, n (%) |
|---|---|---|
Klebsiella spp. | 288 | |
ESBL production | 30 (10.4) | |
Multidrug resistance | 253 (87.84) | |
Acinetobacter spp. | 128 | |
Multidrug resistance | 107 (83.59) | |
Pseudomonas spp. | 114 | |
Multidrug resistance | 84 (73.68) | |
Escherichia coli | 172 | |
ESBL production | 80 (46.5) | |
Multidrug resistance | 124 (72.02) | |
Proteus spp. | 23 | |
ESBL production | 4 (17.4) | |
Enterobacter spp. | 11 | |
ESBL production | 4 (36.36) | |
Staphylococcus aureus | 69 | |
MRSA | 51 (73.9) | |
Coagulase-negative staphylococci | 161 | |
MR-CONS | 125 (77.6) | |
Enterococcus spp. | 151 | |
VRE* | 10 (6.6) | |
Candida spp. | 133 | |
Non-hemolytic streptococci | 18 | |
Others | 12 | |
Total | 1280 |